IE45454L - Cns-active compositions - Google Patents

Cns-active compositions

Info

Publication number
IE45454L
IE45454L IE771509A IE150977A IE45454L IE 45454 L IE45454 L IE 45454L IE 771509 A IE771509 A IE 771509A IE 150977 A IE150977 A IE 150977A IE 45454 L IE45454 L IE 45454L
Authority
IE
Ireland
Prior art keywords
compound
cns
active compositions
gabamimetic
formula
Prior art date
Application number
IE771509A
Other versions
IE45454B1 (en
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7622045A external-priority patent/FR2358881A1/en
Priority claimed from FR7719390A external-priority patent/FR2453643A2/en
Application filed by Synthelabo filed Critical Synthelabo
Publication of IE45454L publication Critical patent/IE45454L/en
Publication of IE45454B1 publication Critical patent/IE45454B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)

Abstract

PHARMACEUTICAL COMPOSITIONS HAVING AN ACTION ON THE CENTRAL NERVOUS SYSTEM The specification discloses pharmaceutical compositions, having an action on the central nervous system, containing a gabamimetic compound and a neuroleptic compound. The gabamimetic compound has the formula and the neuroleptic compound has the formula The compositions of the invention are medicaments which can be used in human therapy in the psychiatric field and, in particular, in the treatment of psychosis. [CA1077846A]
IE1509/77A 1976-07-20 1977-07-19 Pharmaceutical compositions having an action on the central nervous system IE45454B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7622045A FR2358881A1 (en) 1976-07-20 1976-07-20 Neuroleptic compsn. contg. a gabamimetic potentiator - which is a benzylidene-amino-alkanoic acid deriv., for treating e.g. schizophrenia
FR7719390A FR2453643A2 (en) 1977-06-24 1977-06-24 PHARMACEUTICAL COMPOSITIONS ACTIVE ON THE CENTRAL NERVOUS SYSTEM

Publications (2)

Publication Number Publication Date
IE45454L true IE45454L (en) 1978-01-20
IE45454B1 IE45454B1 (en) 1982-08-25

Family

ID=26219550

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1509/77A IE45454B1 (en) 1976-07-20 1977-07-19 Pharmaceutical compositions having an action on the central nervous system

Country Status (11)

Country Link
JP (1) JPS5326327A (en)
AU (1) AU508753B2 (en)
CA (1) CA1077846A (en)
DE (1) DE2732614A1 (en)
GB (1) GB1556567A (en)
IE (1) IE45454B1 (en)
IL (1) IL52550A (en)
LU (1) LU77796A1 (en)
NL (1) NL7708055A (en)
NZ (1) NZ184666A (en)
SE (1) SE7708349L (en)

Also Published As

Publication number Publication date
CA1077846A (en) 1980-05-20
DE2732614A1 (en) 1978-01-26
SE7708349L (en) 1978-01-21
AU508753B2 (en) 1980-04-03
LU77796A1 (en) 1977-10-25
IL52550A (en) 1981-03-31
AU2715177A (en) 1979-01-25
JPS5326327A (en) 1978-03-11
IE45454B1 (en) 1982-08-25
GB1556567A (en) 1979-11-28
NL7708055A (en) 1978-01-24
NZ184666A (en) 1980-04-28
IL52550A0 (en) 1977-10-31

Similar Documents

Publication Publication Date Title
AU556039B2 (en) I.v. therapy or hyperalimentation catheter
DE3070189D1 (en) Medicament, particularly for the treatment of cholera, and pharmaceutical compositions containing it
IL112029A (en) Raloxifine and related compounds for use as medicaments for the treatment of disorders associated with an excess of tachykinin
UA32543C2 (en) Aryl acetamides having analgetic action, a PROCESS for preparation thereof, pharmaceutical composition and a PROCESS for preparation thereof
AU1575776A (en) The treatment of waste
GR3023638T3 (en) Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides, drugs containing these compounds and use of such drugs
NO863313D0 (en) MIXTURE TREATMENT DEVICE.
JPS56103113A (en) Drug for shock treatment
IL49289A (en) N-substituted halo-2-pyrrolidinones, their preparation and their use as herbicides
IL59425A0 (en) N-substituted aziridine-2-carboxylic acid derivatives,processes for preparation thereof and pharmaceutical compositins containing the same
IL56413A (en) Substituted heterocyclic benzamides,their preparation and pharmaceutical compositions containing them
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
FI844491A7 (en) A device for preventing and treating tumors, caries, and other diseases by significantly relieving pain using electrical and/or magnetic pulses.
JPS5252112A (en) Spheroidizing treatment
IL109076A0 (en) Imidazolo-quinoxalinones, their preparation and pharmaceutical compositions containing them
NZ184634A (en) N-(i'allyl-2-pyrrolidylmethyl)-2,3-dimethoxy-5-sulphamoyl-benzamide and pharmaceutical compositions
IT8320023A0 (en) CARBACICLINES, PROCEDURE FOR THEIR PREPARATION AND THEIR USE AS MEDICINES.
JPS568398A (en) Bis*44demethoxidoonorbicin*dihydrazone derivative and its salt acceptable as medicine
AU540498B2 (en) N-substituted 2-amino-3,4-dihydro-pyridives
ES8604731A1 (en) 6,11-Dihydro-11,-oxo-dibenz(b,e)-oxepin derivatives, methods for their preparation, pharmaceutical compositions containing the same and their use as medicaments.
AU1634776A (en) N-SUBSTITUTED c C AMINO METHYL-4HYDROXY 1, 3 BENZENE DIMETHANOI
JPS5775969A (en) N-(1-aryl-2-pyrrolidinylmethyl)-2-methoxy-4- amino-5-methylsulfamoylbenzamide, manufacture and analgesic thereof as effective ingredient
IT8721540A0 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING TRAPIDIL, THEIR PREPARATION PROCEDURE AND THEIR THERAPEUTIC USE.
ZA928127B (en) Use of substituted pyrrolidines, some of which are known, as medicaments, new active substances and processes for their preparation.
SE7708349L (en) PHARMACEUTICAL COMPOSITIONS AND PROCEDURES FOR THE PREPARATION